Rivaroxaban for acute deep venous thrombosis When we have a standard therapy for a disease, in this case vitamin K antagonists (VKA) for deep venous thrombosis (DVT), and a new therapy comes out, what do we want to know about the new drug? Is it at least as effective as the old therapy? Because if …
Is it safe to cardiovert a hemodynamically stable patient with recent onset atrial fibrillation? The evidence says yes, but not everyone is a believer.
Scott Weingart joins ERcast to give his take on 3 factor PCC and FEIBA.
Reversing Anticoagulation – A How to Guide (adapted from podcast interview with Tom Deloughery)
Everything you wanted to know about atrial fibrillation and flutter…and then some more!